Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 1981-1987

  Altintas, Abdullah ^a   Karahan, Zulkuf ^a   Pasa, Semir ^a   Cil, Timucin ^a   Boyraz, Taylan ^a   Iltumur, Kenan ^a   Ayyildiz, Orhan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Essential thrombocythemia; Pulmonary hypertension; Thrombocytosis

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; HYDROXYUREA;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; IRON DEFICIENCY ANEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CATHETERIZATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PLATELET COUNT; PROGNOSIS; PULMONARY ARTERY; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOSIS; TREATMENT OUTCOME;

EID: 35148883400     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701493928     Document Type: Article

References (33)

1. Vassiliou, G. and Green, A. R. (2005) Myeloproliferative disorders. Postgraduate Haematology, pp. 761-782. Blackwell Publishing, Oxford
2. Sanchez, S. and Ewton, A. (2006) Essential thrombocythemia. A review of diagnostic and pathologic features. Arch Pathol Lab Med, 130, pp. 1144-1150.
3. Tefferi, A. (1998) The Philadelphia chromosome negative chronic myeloproliferative disorders: A practical overview. Mayo Clin Proc, 73, pp. 1177-1184.
4. Elliott, M. A. and Tefferi, A. (2005) Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol, 128, pp. 275-290.
5. Schafer, A. I. (2006) Essential thrombocythemia and thrombocytosis. Williams Hematology, pp. 1785-1794. McGraw-Hill Medical
6. van Wolferen, S. A., Grunberg, K. and Noordegraaf, A. V. (2007) Diagnosis and management of pulmonary hypertension over the past 100 years. Respir Med, 101, pp. 389-398.
7. Simonneau, G., Galié, N., Rubin, L. J., Langleben, D., Seeger, W. and Domenighetti, G. (2004) A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 43, pp. 5S-12S.
8. Rubin, L. J. (1997) Primary pulmonary hypertension. N Engl J Med, 336, p. 111.
9. Nands, S. and Orfei, E. (1994) Pulmonary hypertension in polycythemia vera. Am J Hematol, 47, pp. 242-244.
10. Ito, H., Adachi, Y., Arimura, Y., Endo, T., Hinoda, Y. and Imai, K. (2003) A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder. J Gastroenterol, 38, pp. 488-492.
11. Gupta, R., Perumandla, S., Patsiornik, Y., Niranjan, S. and Ohri, A. (2006) Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. J Natl Med Assoc, 98, pp. 1779-1782.
12. Marvin, K. S. and Spellberg, R. D. (1993) Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest, 103, pp. 642-644.
13. Koh, K. H., Cho, S. K., Kim, S. S., Oh, B. H. and Lee, W. Y. (1993) Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis. Int J Cardiol, 41, pp. 168-170.
14. Matsuyama, N., Asada, K., Kondo, K., Kodama, T., Minohara, S. and Hasegawa, S. (1996) Surgical treatment of aortic stenosis with polycythemia vera: A case report. Kyobu Geka, 49, pp. 1097-1099.
15. Nonami, Y., Sasahashi, N., Satoh, K., Ogoshi, S. and Tamiya, T. (1993) A case report: Mitral valve replacement for the patient with essential thrombocythemia. Nippon Kyobu Geka Gakkai Zasshi, 41, pp. 1567-1572.
16. Thiele, J. and Kvasnicka, H. M. (2003) Chronic myeloproliferative disorders with thrombocythemia: A comparative study of two classification systems (PVSG, WHO) on 839 patients. Ann Hematol, 82, pp. 148-152.
17. Harrison, C. N. (2005) Essential thrombocythaemia: Challenges and evidence-based management. Br J Haematol, 130, pp. 153-165.
18. Halank, M., Marx, C., Baretton, G., Müller, K. -M., Ehninger, G. and Höffken, G. (2004) Severe pulmonary hypertension in chronic idiopathic myelofibrosis. Onkologie, 27, pp. 472-474.
19. Garcia-Monero, G., Schuster, S. J., Patrick, H. and Martinez, J. (1999) Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol, 60, pp. 130-135.
20. Dan, K. (2005) Thrombocytosis in iron deficiency anemia. Intern Med, 44, pp. 1025-1026.
21. Nagai, T., Komatsu, N., Sakata, Y., Miura, Y. and Ozawa, K. (2005) Iron deficiency anemia with marked thrombocytosis complicated by central retinal vein occlusion. Intern Med, 44, pp. 1090-1092.
22. Keung, Y. K. and Owen, J. (2004) Iron deficiency and thrombosis: literature review. Clin Appl Thromb Hemost, 10, pp. 387-391.
23. Akins, P. T., Glenn, S., Nemeth, P. M. and Derdeyn, C. P. (1996) Carotid artery thrombus associated with severe iron deficiency anemia and thrombocytosis. Stroke, 27, pp. 1002-1005.
24. Dingli, D., Utz, J. P., Krowka, M. J., Oberg, A. L. and Tefferi, A. (2001) Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest, 120, pp. 801-808.
25. Garypidou, V., Vakalopoulou, S., Dimitriadis, D., Tziomalos, K., Sfikas, G. and Perifanis, V. (2004) Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. Haematologica, 89, pp. 245-247.
26. Michiels, J. J. (2003) Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: A distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts. Pathol Biol, 51, pp. 167-175.
27. Haznedaroǧlu, I. C., Atalar, E., Ozturk, M. A., Ozer, N., Ovunc, K. and Aksoyek, S. (2002) Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension. Platelets, 13, pp. 395-399.
28. Harrison, C. N. and Green, A. R. (2006) Essential thrombocythaemia. Best Pract Res Clin Haematol, 19, pp. 439-453.
29. Jagroop, I. A., Daskalopoulou, S. S. and Mikhailidis, D. P. (2005) Endothelin-1 and human platelets. Curr Vasc Pharmacol, 3, pp. 393-399.
30. Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R. and Lang, I. M. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol, 43, pp. 13S-24S.
31. Damas, J. K., Otterdal, K., Yndestad, A., Aass, H., Solum, N. O. and Froland, S. S. (2004) Soluble CD40 ligand in pulmonary arterial hypertension: Possible pathogenic role of the interaction between platelets and endothelial cells. Circulation, 110, pp. 999-1005.
32. Awabdy, D., Bryan-Lluka, L. J. and Wanstall, J. C. (2003) 5-Hydroxytryptamine and platelets: Uptake and aggregation in hypoxic pulmonary hypertensive rats. Eur J Pharmacol, 459, pp. 1-7.
33. Mandegar, M., Fung, Y. C., Huang, W., Remillard, C. V., Rubin, L. J. and Yuan, J. X. (2004) Cellular and molecular mechanisms of pulmonary vascular remodeling: Role in the development of pulmonary hypertension. Microvasc Res, 68, pp. 75-103.